Congress stock trades today include a notable filing from Rep. Jefferson Shreve, who disclosed a purchase of a JP Morgan 3-year auto callable buffer note, according to a Periodic Transaction Report filed with the U.S. House of Representatives. The transaction is dated December 30, 2025, and was made directly by the member of Congress.
For readers who like to check what stocks senators and representatives buy, this filing stands out mainly for its size. The disclosed amount falls in the range of $5,000,001 to $25,000,000, one of the higher reporting brackets used under the STOCK Act. Because members only have to report a range rather than an exact figure, the true value of the purchase could be anywhere within that window.
What Was Purchased
The asset itself is not a common stock but a structured note issued by JP Morgan, listed in the filing under the CS asset category. Shreve’s own description of the transaction, as entered on the disclosure form, simply reads ‘Structured Note.’ These instruments are typically tied to the performance of an underlying index or basket of securities and often include features like an ‘auto callable’ provision, meaning the issuer can redeem the note early under certain conditions, along with a buffer designed to limit downside losses up to a specified threshold.
The note was purchased through an Advisory Account that the filing identifies as holding Structured Notes, suggesting this account is used specifically for this type of investment rather than for individual equities or mutual funds.
Why This Filing Matters
Whoisbuyingnow.com classifies this transaction as a ‘congress buy’ signal based on the disclosed details. Under the STOCK Act, members of Congress and their families are required to report transactions like this one within 45 days, a rule intended to give the public visibility into potential financial interests that could intersect with legislative work. Filing a Periodic Transaction Report is a routine legal obligation, not an indication of wrongdoing, and this article does not suggest otherwise.
Structured notes like this JP Morgan product are generally less liquid and more complex than standard stocks or bonds, often carrying multi-year terms and conditional payout structures. Their appearance in congressional portfolios is less common than traditional equity holdings, which may explain why this filing is drawing attention among those who track congress stock trades today.
No further details about the specific terms of the note, its underlying reference asset, or its maturity conditions were included in the public filing beyond what is summarized here.